medical robots

The industrial robot market is anticipated to surpass US$ 5,282.40 million in 2023 and is likely to attain a valuation of US$ 25,828.99 million by 2033. The industrial market share is projected to rise at a CAGR of 17.20% from 2023 to 2033, says FMI.

Barrow Neurological Institute in Phoenix, AZ has purchased two Harmony SHR exoskeletons to be used in the hospital’s inpatient and outpatient programs. Barrow’s first robot was delivered last month marking the very first clinical installation for Harmonic Bionics following FDA registration in April of this year. The second unit will be delivered in November and used primarily in Barrow’s outpatient facility.

The U.S. Food and Drug Administration (FDA) has awarded Xenex Disinfection Services a De Novo authorization for its LightStrike+ device, a robot that employs high-intensity, broad-spectrum ultraviolet (UV) light for disinfection. This authorization ushers in a new category of medical device products, wherein the LightStrike+ robot stands as the inaugural and sole product of this kind, establishing a new standard for FDA regulatory procedures concerning UV robots designated for pathogen reduction on non-porous, frequently touched surfaces in healthcare settings.

Medical Robotics Market will reach US$ 72.22 Billion in 2030, according to a report ResearchAndMarkets.com. The medical robotics market has been growing steadily in recent years and is expected to continue in the coming years. As a result, Medical Robotics Market was valued at US$ 11.66 Billion in 2022.

The North America medical robots market is expected to grow from US$ 3,982.30 million in 2022 to US$ 11,112.23 million by 2028; it is estimated to grow at a CAGR of 18.7% from 2022 to 2028, according to The “North America Medical Robots Market Forecast to 2028 – COVID-19 Impact and Regional Analysis By Product, Application, and End User” by ResearchAndMarkets.com.